KCP
MEDP icon

Kera Capital Partners’s Medpace MEDP Stock Holding History

Kera Capital Partners’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$455K Sell
859
-216
-20% -$99.7K 0.04% 353
2026
Q1 		$516K Sell
1,075
-63
-6% -$32.3K 0.06% 232
2025
Q4 		$663K Buy
1,138
+9
+0.8% +$5.11K 0.08% 163
2025
Q3 		$580K Buy
+1,129
New +$493K 0.09% 120

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Kera Capital Partners's MEDP Position: Q2 2026 in Review

Kera Capital Partners reduced its Medpace (MEDP) stake by 20% in Q2 2026, selling an estimated $99.7K and leaving 859 shares worth $455K. The position accounts for 0.04% of the portfolio, ranked #353.

Kera Capital Partners first reported a position in MEDP in Q3 2025 and has held it in 4 quarters since. The position peaked at $663K in Q4 2025. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Kera Capital Partners held 859 shares of Medpace worth $455K as of Q2 2026.
  • Kera Capital Partners sold 216 Medpace shares in Q2 2026, an estimated $99.7K.
  • Medpace made up 0.04% of Kera Capital Partners's portfolio in Q2 2026, its #353 holding.
  • Kera Capital Partners first reported a position in Medpace in Q3 2025 and has held it in 4 quarters since.
  • Kera Capital Partners's Medpace position peaked at $663K in Q4 2025.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Kera Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.